Page last updated: 2024-09-03

thiazole orange and Leishmaniasis, Visceral

thiazole orange has been researched along with Leishmaniasis, Visceral in 1 studies

*Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Abdelhameed, A; Guo, P; Joice, AC; Li, J; Liao, X; McElroy, CA; Rakotondraibe, L; Slebodnick, C; Werbovetz, KA; Wilson, WD1

Other Studies

1 other study(ies) available for thiazole orange and Leishmaniasis, Visceral

ArticleYear
Synthesis and antileishmanial evaluation of thiazole orange analogs.
    Bioorganic & medicinal chemistry letters, 2020, 01-01, Volume: 30, Issue:1

    Topics: Animals; Benzothiazoles; Drug Discovery; Leishmaniasis, Visceral; Quinolines

2020